Salt intake and reductions in arterial pressure and proteinuria - Is there a direct link?

被引:20
作者
Bakris, GL
Weir, MR
机构
[1] Rush University Hypertension Center, Department of Preventive Medicine Rush Medical School, University of Illinois Medical Center, Chicago, IL
[2] Division of Nephrology, Department of Medicine, University of Maryland Medical School, Baltimore, MD
[3] Rush University Hypertension Center, Chicago, IL 60612
关键词
salt; diet; antihypertensive therapy; drugs; salt sensitivity;
D O I
10.1016/S0895-7061(96)00392-5
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The preponderance of the medical literature supports the concept that modest or moderate dietary salt restriction enhances the blood pressure lowering responses to most antihypertensive medications and may permit either dose reduction or, in a few cases, complete drug withdrawal. Moreover, reduction in salt intake has a permissive action on the antiproteinuric responses of angiotensin converting enzyme inhibitors and nondihydropyridine calcium channel blockers. It does not, however, affect proteinuria in those receiving dihydropyridine calcium channel blockers. The importance of selecting out those individuals who can most benefit from dietary salt modification (the ''salt sensitive'' groups of hypertensive patients) is important. Prospective randomized clinical studies are needed to assess the correlation between dietary salt intake and renal endpoints, such as time dialysis. This will be particularly important in different demographic groups that may have a greater predisposition to salt sensitivity, such as elderly or obese hypertensives, hypertensives of black or Hispanic descent, and those with non-insulin-dependent diabetes mellitus. (C) 1996 American Journal of Hypertension, Ltd.
引用
收藏
页码:S200 / S206
页数:7
相关论文
共 75 条
  • [11] BEARD TC, 1982, LANCET, V2, P455
  • [12] MICROALBUMINURIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION - EFFECTS OF SEVERAL ANTIHYPERTENSIVE DRUGS
    BIANCHI, S
    BIGAZZI, R
    BALDARI, G
    CAMPESE, VM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1992, 93 (05) : 525 - 528
  • [13] MICROALBUMINURIA IN SALT-SENSITIVE PATIENTS - A MARKER FOR RENAL AND CARDIOVASCULAR RISK-FACTORS
    BIGAZZI, R
    BIANCHI, S
    BALDARI, D
    SGHERRI, G
    BALDARI, G
    CAMPESE, VM
    [J]. HYPERTENSION, 1994, 23 (02) : 195 - 199
  • [14] BING RF, 1979, LANCET, V2, P121
  • [15] MOLECULAR-BASIS OF PROTEINURIA OF GLOMERULAR ORIGIN
    BRENNER, BM
    HOSTETTER, TH
    HUMES, HD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (15) : 826 - 833
  • [16] THE SURVIVAL OF TREATED HYPERTENSIVE PATIENTS AND THEIR CAUSES OF DEATH - A REPORT FROM THE DHSS HYPERTENSIVE CARE COMPUTING PROJECT (DHCCP)
    BULPITT, CJ
    BEEVERS, DG
    BUTLER, A
    COLES, EC
    HUNT, D
    MUNROFAURE, AD
    NEWSON, RB
    ORIORDAN, PW
    PETRIE, JC
    RAJAGOPALAN, B
    RYLANCE, PB
    TWALLIN, G
    WEBSTER, J
    DOLLERY, CT
    [J]. JOURNAL OF HYPERTENSION, 1986, 4 (01) : 93 - 99
  • [17] ABNORMAL RENAL HEMODYNAMICS IN BLACK SALT-SENSITIVE PATIENTS WITH HYPERTENSION
    CAMPESE, VM
    PARISE, M
    KARUBIAN, F
    BIGAZZI, R
    [J]. HYPERTENSION, 1991, 18 (06) : 805 - 812
  • [18] CAMPESE VM, 1992, HYPERTENSION, V19, P403
  • [19] EFFECTS OF DIFFERENT CALCIUM-ANTAGONISTS ON PROTEINURIA ASSOCIATED WITH DIABETES-MELLITUS
    DEMARIE, BK
    BAKRIS, GL
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 113 (12) : 987 - 988
  • [20] THE RELATION OF A CIRCULATING SODIUM-TRANSPORT INHIBITOR (THE NATRIURETIC HORMONE) TO HYPERTENSION
    DEWARDENER, HE
    MACGREGOR, GA
    [J]. MEDICINE, 1983, 62 (05) : 310 - 326